CSL Hong Kong Aleviate Human Coagulation Factor VIII 250IU/von Willebrand factor 500IU complex, Powder for injection (50 IU/mL FVIII)

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

Factor VIII, Quantity: 250 IU; Von willebrand factor, Quantity: 500 IU

Доступна с:

CSL Behring Australia Pty Ltd

ИНН (Международная Имя):

Factor VIII,Von willebrand factor

Фармацевтическая форма:

Injection, solution

состав:

Excipient Ingredients: water for injections

Администрация маршрут:

Intravenous

Штук в упаковке:

Not Required

Тип рецепта:

(S1) This Schedule is intentionally blank

Терапевтические показания :

Aleviate is indicated for: ? the treatment of bleeding episodes including surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. ? the treatment and prophylaxis of bleeding associated with factor FVIII deficiency due to haemophilia A.

Обзор продуктов:

Visual Identification: Clear, colourless solution; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Статус Авторизация:

Licence status A

Дата Авторизация:

2004-06-17